102 related articles for article (PubMed ID: 3307575)
1. Prostacyclin and PGE1 treatment of pulmonary hypertension.
Long WA; Rubin LJ
Am Rev Respir Dis; 1987 Sep; 136(3):773-6. PubMed ID: 3307575
[TBL] [Abstract][Full Text] [Related]
2. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
3. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
[TBL] [Abstract][Full Text] [Related]
4. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration.
Serra W; Musiari L; Ardissino D; Gherli T; Montanari A
Int J Cardiol; 2011 Jan; 146(1):e10-5. PubMed ID: 19176262
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
[TBL] [Abstract][Full Text] [Related]
6. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
Naeije R; Mélot C; Mols P; Hallemans R
Am Rev Respir Dis; 1982 Jan; 125(1):1-5. PubMed ID: 6802045
[TBL] [Abstract][Full Text] [Related]
7. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
8. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
[TBL] [Abstract][Full Text] [Related]
9. Use of prostacyclin and its analogues in the treatment of cardiovascular disease.
Fink AN; Frishman WH; Azizad M; Agarwal Y
Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602
[TBL] [Abstract][Full Text] [Related]
10. The role of prostacyclin in the treatment of primary pulmonary hypertension: the Cambridge experience.
Cremona G
Cardiologia; 1993 Dec; 38(12 Suppl 1):227-32. PubMed ID: 8020021
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange.
Mélot C; Lejeune P; Leeman M; Moraine JJ; Naeije R
Am Rev Respir Dis; 1989 Jan; 139(1):106-10. PubMed ID: 2912329
[TBL] [Abstract][Full Text] [Related]
13. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
14. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandin E1 (PGE1) in pulmonary hypertension due to chronic obstructive pulmonary disease (COPD).
Meissner E; Creutzig A; Fabel H
Prog Clin Biol Res; 1989; 301():253-7. PubMed ID: 2798450
[No Abstract] [Full Text] [Related]
16. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
[TBL] [Abstract][Full Text] [Related]
17. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.
Conte JV; Gaine SP; Orens JB; Harris T; Rubin LJ
J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232
[TBL] [Abstract][Full Text] [Related]
18. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
Prielipp RC; Rosenthal MH; Pearl RG
Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
[TBL] [Abstract][Full Text] [Related]
20. Role of prostacyclin in the treatment of primary pulmonary hypertension.
Cremona G; Higenbottam T
Am J Cardiol; 1995 Jan; 75(3):67A-71A. PubMed ID: 7840058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
